Clinical trial

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the…

NCT00344253 · Heidelberg University, Other · Completed

Key facts

NCT number NCT00344253
Title Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Official title A Monocentric, Randomized, Controlled Trial to Test the Efficacy of Interferon-beta in the Treatment of Disseminated Encephalomyelitis (ED)-Associated and Primary Intermediate Uveitis in Comparison to Standard Treatment (TEAM)
Lead sponsor Heidelberg University, Other
Collaborators Serono GmbH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Uveitis, Intermediate, Macular Edema, Multiple Sclerosis
Intervention type Drug
Interventions Interferon beta, Methotrexate
Enrollment 19
Start date Mar 1, 2006
Primary completion Mar 1, 2011
Completion Jan 1, 2012
First posted Jun 26, 2006
Last update posted Dec 3, 2012
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies